| WKN: | A0MSMZ |
| ISIN: | US03152W1099 |
| Land: | USA |
| Branche: | Chemie, Pharma, Bio- & Medizintechnik |
| Sektor: | Biotechnologie |
Weshalb die Amicus Therapeutics-Aktie
ein B-Rating hat,
erfahren Sie im Performance-Check
vom 11. März 2026 Info.
| Rang | Datum | Vorjahr | Schluss | Performance |
|---|---|---|---|---|
| 1 | 2014 | 1,59 | 6,76 | 325,16% |
| 2 | 2017 | 4,57 | 12,09 | 164,55% |
| 3 | 2020 | 8,60 | 18,30 | 112,79% |
| 4 | 2010 | 2,68 | 3,54 | 32,09% |
| 5 | 2025 | 9,15 | 12,00 | 31,15% |
| 6 | 2015 | 6,76 | 8,71 | 28,85% |
| 7 | 2023 | 11,15 | 13,20 | 18,39% |
| 8 | 2019 | 7,93 | 8,60 | 8,45% |
| 9 | 2022 | 10,50 | 11,15 | 6,19% |
| 10 | 2026 | 12,00 | 12,20 | 1,67% |
| 11 | 2012 | 2,55 | 2,06 | -19,22% |
| 12 | 2013 | 2,06 | 1,59 | -22,82% |
| 13 | 2011 | 3,54 | 2,55 | -27,97% |
| 14 | 2024 | 13,20 | 9,15 | -30,68% |
| 15 | 2018 | 12,09 | 7,93 | -34,41% |
| 16 | 2021 | 18,30 | 10,50 | -42,62% |
| 17 | 2016 | 8,71 | 4,57 | -47,53% |
| 18 | 2009 | 5,47 | 2,68 | -51,01% |
| Rang | Datum | Vorjahr | Schluss | Performance |
|---|---|---|---|---|
| 1 | 2009 | 5,47 | 2,68 | -51,01% |
| 2 | 2016 | 8,71 | 4,57 | -47,53% |
| 3 | 2021 | 18,30 | 10,50 | -42,62% |
| 4 | 2018 | 12,09 | 7,93 | -34,41% |
| 5 | 2024 | 13,20 | 9,15 | -30,68% |
| 6 | 2011 | 3,54 | 2,55 | -27,97% |
| 7 | 2013 | 2,06 | 1,59 | -22,82% |
| 8 | 2012 | 2,55 | 2,06 | -19,22% |
| 9 | 2026 | 12,00 | 12,20 | 1,67% |
| 10 | 2022 | 10,50 | 11,15 | 6,19% |
| 11 | 2019 | 7,93 | 8,60 | 8,45% |
| 12 | 2023 | 11,15 | 13,20 | 18,39% |
| 13 | 2015 | 6,76 | 8,71 | 28,85% |
| 14 | 2025 | 9,15 | 12,00 | 31,15% |
| 15 | 2010 | 2,68 | 3,54 | 32,09% |
| 16 | 2020 | 8,60 | 18,30 | 112,79% |
| 17 | 2017 | 4,57 | 12,09 | 164,55% |
| 18 | 2014 | 1,59 | 6,76 | 325,16% |